INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 226 filers reported holding INSMED INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,664,322 | +3.9% | 1,808,488 | -13.2% | 0.20% | +6.4% |
Q2 2023 | $43,948,726 | +16.4% | 2,082,878 | -6.0% | 0.19% | +1.1% |
Q1 2023 | $37,768,256 | -11.6% | 2,215,147 | +3.6% | 0.19% | -28.7% |
Q4 2022 | $42,734,563 | +14.6% | 2,138,867 | +23.6% | 0.26% | +9.7% |
Q3 2022 | $37,275,000 | -34.7% | 1,730,508 | -40.2% | 0.24% | -31.0% |
Q2 2022 | $57,066,000 | -11.5% | 2,893,822 | +5.5% | 0.34% | +2.7% |
Q1 2022 | $64,474,000 | +10.8% | 2,743,579 | +28.4% | 0.34% | +10.9% |
Q4 2021 | $58,201,000 | -3.4% | 2,136,586 | -2.3% | 0.30% | -7.3% |
Q3 2021 | $60,238,000 | -15.4% | 2,187,275 | -12.6% | 0.33% | -18.7% |
Q2 2021 | $71,186,000 | +17.6% | 2,501,279 | +40.7% | 0.40% | +5.8% |
Q1 2021 | $60,545,000 | +96.0% | 1,777,613 | +91.5% | 0.38% | +94.9% |
Q4 2020 | $30,896,000 | -15.5% | 928,091 | -18.5% | 0.20% | -29.9% |
Q3 2020 | $36,582,000 | +20.0% | 1,138,222 | +2.8% | 0.28% | +4.1% |
Q2 2020 | $30,482,000 | +120.9% | 1,106,833 | +28.6% | 0.27% | +80.4% |
Q1 2020 | $13,800,000 | – | 860,913 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |